About Dr Mike Stanton
Mike’s work primarily focuses on the development of novel molecular imaging techniques for the non-invasive detection of bacteria in a living host. The work also involves the development of novel cancer therapeutics based on the use of bacteria.
Theme / Team
Microbes & Cancer
Lung cancer, Ovarian cancer, Breast cancer, Prostate cancer, Pancreatic cancer
Mike obtained his undergraduate degree in Genetics from University College Cork before pursuing a Masters degree in Regenerative medicine in the National University of Ireland, Galway. Mike completed his PhD in cancer gene therapy and optical imaging in the Cork Cancer Research Centre as part of the PhD Scholars Programme in Cancer Biology. His doctoral research mainly focused on the development of novel imaging and therapeutic strategies utilising tumour targeting bacteria for the treatment and diagnosis of cancer.
Mike is currently undertaking postdoctoral research as part of the EU funded Vaccines and Imaging Partnership (VIP) and has been on secondment in GSK vaccines in Siena, Italy since March 2016. VIP is a multicentre academia/industry collaborative network, the aim of which is to develop novel methods for the detection of bacteria in the body a range of diseases.